Should you buy Teva Pharmaceutical Industries Limited stock? (NYSE:TEVA). Let's see how it does in our automated value investing analysis system.
(Teva Pharmaceutical Industries Limited stock price per share)
||TEVA Fair Price
(based on intrinsic value)
|TEVA Safety Price (based on a variable margin of safety)||$30.37|
|PE Ratio versus Sector||1735% higher than other Healthcare stocks|
|PE Ratio versus Industry||1186% higher than other Unknown stocks|
|Free Cash Flow Jitter||155%|
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 35,573,857 shares shorted. With 1,097,267,243 shares available for purchase and an average trading volume over the past 10 trading days of 11,831,371, it would take at least 3.007 days for all of the short holders to cover their shorts.
We believe that Teva Pharmaceutical Industries Limited may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Even better, Teva Pharmaceutical Industries Limited looks like a stock on sale. Based on our analysis—if the company keeps making money the way it has been—you may be looking at a bargain. Keep this stock in mind as you put together your portfolio! See Before You Buy for your next steps (and read our disclaimer about investing risk).
Does Teva Pharmaceutical Industries Limited have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles